ORKA - Latest News
Oruka Therapeutics, Inc. (ORKA), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $3.25B. Beta to the broader market is -0.40.
The article list below shows the most recent ORKA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ORKA Headlines
Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean
fool.com - Jun 27, 2026
This biotech innovator in monoclonal antibody therapies reported a notable insider sale amid ongoing clinical-stage developments.
Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors?
fool.com - Jun 24, 2026
Arjun Agarwal sold 10,290 shares for a transaction value of approximately ~$608,000, based on a weighted average price of $59. 07 per share on May 18,
Oruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock?
zacks.com - Jun 12, 2026
Oruka Therapeutics, Inc. (ORKA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank
Wall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to Trade
zacks.com - Jun 10, 2026
The mean of analysts' price targets for Oruka Therapeutics, Inc. (ORKA) points to an 111.
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million
fool.com - May 31, 2026
This clinical-stage biotech focused on antibody therapies for immunological disorders reported a notable insider sale in its latest filing.
How News Affects ORKA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ORKA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ORKA news questions
- What is the latest ORKA news headline?
- The most recent ORKA headline (Jun 27, 2026) is "Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ORKA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ORKA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ORKA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.